Compugen News, Compugen Quote, CGEN Quote

Compugen (NQ:CGEN) Delayed: 2.59 +0.03 (1.17%)

Prev. Close

$2.56

Today 6M 1Y 5Y

Open

$2.56

52 Wk High

$7.79

52 Wk Low

$4.32

Day High

$2.60

Day Low

$2.53

P/E

N/A

EPS

$-0.36

Volume

168,927

Friends, Peers and Foes (?): CW9, AZN, DSNKY, ALLT, BLRX (more...)

ALERTS | RSS

Aug 26, 2026 07:00 AM Daiichi Sankyo and AstraZeneca start phase 3 urothelial cancer trial
Aug 26, 2026 07:00 AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
Aug 4, 2026 06:53 AM H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN)
Aug 3, 2026 08:00 AM Form 6-K COMPUGEN LTD For: Aug 03
Aug 3, 2026 07:21 AM Compugen (CGEN) Tops Q2 EPS by 1c
Aug 3, 2026 07:03 AM Form 6-K COMPUGEN LTD For: Jun 30
Aug 3, 2026 07:00 AM Compugen Reports Second Quarter 2026 Results
Jul 30, 2026 04:14 PM Form 4 COMPUGEN LTD For: Jul 29 Filed by: Levine Zurit
Jul 30, 2026 04:11 PM Form 4 COMPUGEN LTD For: Jul 29 Filed by: Silberman David
Jul 30, 2026 04:10 PM Form 4 COMPUGEN LTD For: Jul 29 Filed by: Ophir Eran

Entities mentioned with CGEN

View All Entities